World Cancer Day
Every year on World Cancer Day we reflect on all the progress made in recent years and think about what more we can do for people who suffer from cancer.
Bristol Myers Squibb is proud to join the fight against cancer by raising awareness, and thinking about the breakthrough treatments of tomorrow that will help even more patients. As pioneers who made the first immunotherapy accessible, we believe in the power of science to develop innovative medicines that have the potential to transform patients' lives.
On the occasion of World Cancer Day, Dr. Paul Lacante, Medical Director at Bristol Myers Squibb Benelux and EU Cluster, shared his view on the evolution of cancer treatment over the past decades and the future that is ahead.
"We must continue the search for innovative treatments"
Prof. Dr. John Haanen, internist-oncologist at the Dutch Cancer Institute
"Medical breakthroughs of the last decade have changed the lives of patients"
Koen van Elst, Stichting Melanoom
World Cancer Day held every 4 February is the global uniting initiative led by the Union for International Cancer Control (UICC).
By raising worldwide awareness, improving education and catalysing personal, collective and government action, we are all working together to reimagine a world where millions of preventable cancer deaths are saved and access to life-saving cancer treatment and care is equitable for all - no matter who you are or where you live.
Every year, Bristol Myers Squibb employees around the world come together and express their unwavering commitment to cancer research. Around the world, they participate in the Country 2 Country 4 Cancer rides.
In 2022, 6 BMS employees from Belgium and the Netherlands rode their bike through France and Belgium to rise money for the Foundation against Cancer in Belgium and the charity Stichting Merels Wereld in the Netherlands.
We discover, develop, and deliver innovative medicines
We believe in the power of science to tackle some of the most challenging diseases of our time. We have a long history of developing life-saving medicines and a promising pipeline to shape the next generation of treatment options across multiple indications and therapeutic areas.